Genetic Engineering, Pharma Companies and Protein

COVID prompts another milestone, as India clears first DNA vaccine

pharmaphorum

AUGUST 23, 2021

The vaccine may be a latecomer to the COVID-19 vaccine arsenal, but its approval signals the potential of DNA vaccines and is a boost to companies working in this space. The plasmid harnesses cellular machinery to create the spike protein, which is recognised as foreign by the immune system and stimulates an immune response.

DNA

DNA Vaccine Vaccination Genetic Engineering

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

XTalks

AUGUST 17, 2020

protein-based biologics) and vaccine treatments. protein-based biologics) : are those which bind to specific components (i.e. A growing area in the immunotherapy space is the development of biological modulators, which are genetically engineered proteins that target specific components of the immune system.

Protein

Protein Engineer Immune Response In-Vivo

Clinical Research Informer

COVID prompts another milestone, as India clears first DNA vaccine

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

Webinars

Stay Connected